ALLO - Allogene Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ALLO is currently covered by 13 analysts with an average price target of $10.97. This is a potential upside of $9.69 (757.03%) from yesterday's end of day stock price of $1.28.

Allogene Therapeutics's activity chart (see below) currently has 125 price targets and 125 ratings on display. The stock rating distribution of ALLO is 82.86% BUY and 17.14% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 22.74% with an average time for these price targets to be met of 78.4 days.

Highest price target for ALLO is $14, Lowest price target is $5, average price target is $8.6.

Most recent stock forecast was given by ASTHIKA GOONEWARDENE from TRUIST on 13-May-2025. First documented stock forecast 04-Nov-2018.

Currently out of the existing stock ratings of ALLO, 29 are a BUY (82.86%), 6 are a HOLD (17.14%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$10

$8.72 (681.25%)

2 months ago
(13-May-2025)

2/10 (20%)

$9.05 (952.63%)

94

Buy

$9

$7.72 (603.13%)

$10

2 months ago
(13-May-2025)

0/3 (0%)

$8.05 (847.37%)

Buy

$7

$5.72 (446.88%)

$9

2 months ago
(13-May-2025)

2/9 (22.22%)

$6.05 (636.84%)

3

Buy

$8

$6.72 (525.00%)

$9

3 months 25 days ago
(18-Mar-2025)

0/10 (0%)

$6.31 (373.37%)

Buy

$14

$12.72 (993.75%)

4 months ago
(13-Mar-2025)

1/3 (33.33%)

$12.06 (621.65%)

192

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ALLO (Allogene Therapeutics) average time for price targets to be met?

On average it took 78.4 days on average for the stock forecasts to be realized with a an average price target met ratio 22.74

Which analyst has the current highest performing score on ALLO (Allogene Therapeutics) with a proven track record?

MARK BREIDENBACH

Which analyst has the most public recommendations on ALLO (Allogene Therapeutics)?

Mark Breidenbach has 1 price targets and 6 ratings on ALLO

Which analyst is the currently most bullish on ALLO (Allogene Therapeutics)?

Luca Issi with highest potential upside - $30.49

Which analyst is the currently most reserved on ALLO (Allogene Therapeutics)?

Dane Leone with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?